2021
DOI: 10.3390/ijms22168671
|View full text |Cite
|
Sign up to set email alerts
|

mTOR Knockdown in the Infralimbic Cortex Evokes A Depressive-like State in Mouse

Abstract: Fast and sustained antidepressant effects of ketamine identified the mammalian target of rapamycin (mTOR) signaling pathway as the main modulator of its antidepressive effects. Thus, mTOR signaling has become integral for the preclinical evaluation of novel compounds to treat depression. However, causality between mTOR and depression has yet to be determined. To address this, we knocked down mTOR expression in mice using an acute intracerebral infusion of small interfering RNAs (siRNA) in the infralimbic (IL) … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(13 citation statements)
references
References 90 publications
1
12
0
Order By: Relevance
“…We indeed observed that the hippocampal HO-1/CO system is involved in the depressive-like state of the animals, and CO-RM-3 administration can reverse the depressive-like symptoms. CO is known for its neuroprotective effects in the cortical amygdala and hippocampal neurons ( Hettiarachchi et al, 2014 ; Wang et al, 2017 ; Riego et al, 2018 ); the brain regions are involved in depression ( Sheline et al, 2002 ; Whalen et al, 2002 ; Liu et al, 2017b ; Seo et al, 2017 ; Du Preez et al, 2021 ; Garro-Martinez et al, 2021 ; Li et al, 2021 ; Ouyang et al, 2021 ; Qin et al, 2021 ; Sindermann et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…We indeed observed that the hippocampal HO-1/CO system is involved in the depressive-like state of the animals, and CO-RM-3 administration can reverse the depressive-like symptoms. CO is known for its neuroprotective effects in the cortical amygdala and hippocampal neurons ( Hettiarachchi et al, 2014 ; Wang et al, 2017 ; Riego et al, 2018 ); the brain regions are involved in depression ( Sheline et al, 2002 ; Whalen et al, 2002 ; Liu et al, 2017b ; Seo et al, 2017 ; Du Preez et al, 2021 ; Garro-Martinez et al, 2021 ; Li et al, 2021 ; Ouyang et al, 2021 ; Qin et al, 2021 ; Sindermann et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, to overcome this limitation, it is desirable that further studies are performed on suitable animal models. Moreover, it would be interesting to evaluate the effect of irisin administration on the mammalian target of the rapamycin (mTOR)-signaling pathway that plays a key role in the preclinical tests of novel antidepressant drugs [ 67 ]. Finally, further studies on aged animal models will be needed to focus on the interplay among MDD, dementia, and neurodegenerative diseases, as depression is not only the most frequent noncognitive disorder associated with cognitive deficits but also a risk factor that contributes to worsening the neurodegeneration [ 68 ].…”
Section: Limitations and Future Directionsmentioning
confidence: 99%
“…Developing animal models of human illnesses is a challenging task for translational research, but it is indispensable to understanding pathomechanism, searching for biomarkers, and engineering novel treatment [ 156 , 157 , 158 , 159 , 160 , 161 , 162 , 163 , 164 ]. Migraine research is no exception.…”
Section: Animal Models Of Neurogenic Inflammationmentioning
confidence: 99%